Rolvedon
NDC 76961-101, eflapegrastim-xnst, injection, solution, from Spectrum Pharmaceuticals, Inc..
- Product NDC
- 76961-101
- Status
- Listed
- Labeler
- Spectrum Pharmaceuticals, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761148
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76961-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EFLAPEGRASTIM13.2 mg/.6mL
Pharmacologic classes
Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76961-101-01 | 76961010101 | .6 mL in 1 SYRINGE, GLASS (76961-101-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/6e436115-62e7-4729-aeb0-ff78ea685206Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=76961-101
Use it
Look up 76961-101 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76961-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76961-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.